AlphaYouBF
Schedule 13G filing
BCLS Fund III Investments, LP disclosed a 6.3% stake in ADARx Pharmaceuticals, Inc. (ADRX)
BCLS Fund III Investments, LP reported owning 6.3% of ADARx Pharmaceuticals, Inc. (ADRX) (6,728,970 shares) in a Schedule 13G filed Oct 1, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 1, 2026
- Source
- Schedule 13G
More ADRX insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.